Autoantibodies, including rheumatoid factor (RF), are an important characteristic of rheumatoid arthritis (RA). Interestingly, several studies reported a correlation between the presence of immunoglobulin A autoantibodies and worse disease course. We previously demonstrated that triggering the IgA Fc receptor (FcaRI) on neutrophils results in neutrophil recruitment and release of neutrophil extracellular traps (NETs).
Introduction
Rheumatoid arthritis (RA) is a systemic chronic autoimmune disease, which is characterized by inflammation of the joints 1 . This disease leads to long-term joint damage, resulting in chronic pain, loss of function and disability in patients. RA has a prevalence of 1% and is two to three times more common in women than men. The cause of RA is unknown and the molecular pathology is still poorly understood, but it is likely a multifactorial disease in which both genetics and environmental factors play crucial roles 2 . An important characteristic of RA is the presence of autoantibodies. These include rheumatoid factors (RF), which are autoantibodies specifically directed against the Fc domain of immunoglobulin G (IgG) 3, 4 . A second type of RA-related autoantibodies are anti-citrullinated protein antibodies (ACPA) 5, 6 . The combination of RF and ACPA is generally accepted as a diagnostic tool by most rheumatologists.
RF and ACPA can be of the IgM, IgG or IgA antibody subclasses. Although some conflicting results were reported 7 , most studies suggested a correlation between the presence of IgA RF in blood or synovial fluid and worse disease prognosis as well as severe manifestations in RA 4, [8] [9] [10] [11] [12] [13] [14] [15] . A recent study showed that the amount of IgA RF was significantly associated with severity of disease in RA patients that were IgM RF negative. No correlation was found between IgG RF levels and the severity of RA disease 10 . Furthermore, IgA RF were also implicated in extra-articular disease manifestations 11 . In a large patient cohort study, a positive correlation was found between increased serum IgA and the grade of cartilage damage in active RA 12 . Anti-tumor necrosis factor (TNF)-a treatment of RA patients was shown to reduce RF levels and alleviated disease 16, 17 . However, patients with high pre-treatment IgA RF levels had a poor clinical response to TNF-a inhibitors 16, 17 .
IgA RF or IgA anti-CCP antibodies have been reported to possess predictive value for the progression of disease 13 . Taken together, these data prompted us to hypothesize that IgA autoantibodies might be involved in causing joint cartilage erosions in active RA disease, as we previously demonstrated that IgA antibodies potently activate polymorphonuclear cells (PMNs; neutrophils) 18, 19 . These are abundant circulating effector cells of the innate immune system that have long been viewed as short-lived cells with a primary function in bacterial elimination 20 . However, excessive neutrophil activation can result in severe tissue damage and chronic inflammation as they contain a multitude of granules containing cytotoxic molecules 21 . We demonstrated that crosslinking of FcaRI by IgA complexes induced release of the chemoattractant leukotriene B4 (LTB4), leading to amplification of neutrophil migration 18 . Furthermore, the hypothesis that IgA-FcaRI interactions play a harmful role in autoimmune diseases is supported by our previous results investigating the rare skin blistering disease Linear IgA Bullous Disease (LABD) 22 . LABD is characterized by IgA autoantibodies directed against collagen XVII and neutrophil influx in the skin of patients, as well as extensive skin damage and blister formation. We previously demonstrated that neutrophil activation and concomitant tissue damage is a direct consequence of FcaRI triggering through IgA autoantibodies 19 . Moreover, nowadays it is more appreciated that neutrophils can secrete a multitude of anti-and proinflammatory mediators and play a role in inducing (in)appropriate innate and adaptive immune responses 23 . Neutrophils express FcaRI, which is a member of the Fc receptor Ig superfamily [24] [25] [26] [27] . Crosslinking of FcaRI by IgA complexes induces multiple proinflammatory functions, including phagocytosis, respiratory burst, degranulation, antibody-dependent-cellular cytotoxicity, release of cytokines and inflammatory mediators 28 . Additionally, neutrophils have the ability to release neutrophil extracellular traps (NETs), which is increased after crosslinking of FcaRI by IgA antibodies 29 . NETs are web-like structures that can trap and possibly kill bacteria and fungi. NETs contain DNA, histones and several granular and cytoplasmic antimicrobial proteins, like elastase and myeloperoxidase (MPO) 30, 31 . NETs release has been implicated in the pathology of different autoimmune disorders, such as systemic lupus erythematosus (SLE) and RA [32] [33] [34] [35] [36] . As neutrophils are found in high numbers in the SF of RA patients, we investigated whether IgA autoantibody complexes in plasma and SF of RA patients activate neutrophils and induce NETs release.
Materials and Methods

Patients
Plasma (21 patients) and synovial fluids (5 patients) of diagnosed RA patients were collected during their visit to the rheumatology department at VU University Medical Center (see Table I for patient characteristics). Patients gave their written informed consent to their involvement in the study in accordance with the guidelines of the Medical Ethical Committee of the VU University Medical Center (The Netherlands).
Isolation of human PMNs from healthy controls
PMNs were isolated from peripheral blood that was obtained from healthy donors using Lymphoprep (Axis-Shield, Oslo, Norway) density gradient centrifugation, after which erythrocytes were lysed in ammonium chloride buffer (155 mM NH 4 Cl, 10 mM KHCO 3 and 0.11 mM EDTA, 10 minutes, RT). After lysis, PMNs were washed with phosphatebuffered saline (PBS; B.Braun, Melsungen, Germany). Cells were resuspended in RPMI 1640 (Gibco BRL, Paisley, UK) supplemented with glutamine and antibiotics. Additionally, a low concentration of 1% heat-inactivated fetal calf serum was added (60 minutes, 70 °C), because fetal calf serum contains heat stable nucleases that can interfere or break down NETs 37 (medium hereafter referred to as RPMI 1%). Before experiments, isolated
PMNs were allowed to settle for 1 hour at 37 °C. Blood samples were collected after donors gave informed consent, in accordance with the guidelines of the Medical Ethical
Committee of the VU University Medical Center (The Netherlands). For plasma collection (8 healthy volunteers), blood was diluted 1:1 with PBS, and Lymphoprep (Axis-Shield, Oslo, Norway) density gradient centrifugation was performed. The plasma fraction (1:1 diluted in PBS) was collected and stored at -80 °C in aliquots until use.
Preparation of plasma and SF
After SF collection, samples were centrifuged at 3420 x g for 5 minutes. 
Precipitation of RF immune complexes from plasma and SF
Immune complexes were precipitated from plasma and SF with polyethylene glycol (PEG) 6000. Plasma and SF were centrifuged at 3420 x g for 5 minutes before use. Supernatants were mixed with an equal volume of 10% PEG6000 (final concentration of 5% PEG 6000).
After overnight incubation at 4°C, precipitates were collected by centrifugation for 10 minutes at 9560 x g. Precipitates were solved in PBS to the original volume of the plasma or SF and placed on ice for use at the same day in experiments.
Preparation of soluble heat-aggregated IgA
Aggregation of IgA was performed by diluting serum IgA (Cappel, MP Biomedicals, Santa Ana, CA) in PBS and by heating for 30 minutes at 63 C. After cooling down to RT, the protein was centrifuged at 10.000 x g for 2 minutes to remove the insoluble aggregates.
The supernatant was then used as the heat-aggregated IgA.
Live cell imaging
For monitoring of NET release in time, nuclei of isolated live PMNs were labeled with Hoechst nucleic acid stain (1:1000; Invitrogen Life Technologies, Carlsbad, CA) in RPMI 1% (30 minutes, 37°C). Cells were washed and allowed to settle (1 hour, 37°C), after which they were incubated in Ibidi µ-slides (Ibidi, Martinsried, Germany) (2x10 5 /well).
Additionally, the nucleic acid label SYTOX green (2.5 µg/ml; Invitrogen Life Technologies) was added to the medium to detect the presence of extracellular DNA during recording.
PMNs were stimulated with 1-5% PEG 6000 precipitates of RA patients' plasma or SF and monitored in time at 37°C with live cell microscopy (Olympus IX81, Tokyo, Japan).
Immunofluorescence staining of NETs
PMNs were added to Lab-Tek Chamberslides (1.5x10 5 /well; Nalge NUNC, Rochester, NY) and stimulated with non-precipitated plasma or SF as well as 1-5% PEG 6000 precipitates for 3 hours at 37°C. After incubation, cells were fixed for 15 minutes at RT with 4% paraformaldehyde, after which the fixative was removed. Slides were stained with DAPI 
Binding and uptake of complexes by neutrophils
PMNs were incubated with PEG 6000 precipitated samples or heat-aggregated IgA at 4°C for 1 hour, followed by incubation at 37°C for 30 minutes. After incubation, cells were washed and cytospins were made. Slides were fixed for 10 minutes at RT with acetone.
Immunofluorescence was performed and cytospins were stained for IgA (Polyclonal ) were stimulated with 1-5% PEG 6000 precipitates from RA patients plasma or SF or heat-aggregated IgA. Optical density was measured every 5 minutes for 3 hours in a preheated fluorimeter at 37°C
(FLUOstar/POLARstar) at 480 nm excitation, 520 nm emission.
Measurement of lactoferrin in supernatant of stimulated cells
Lactoferrin was measured in the supernatants of PMNs (in duplicate) that had been stimulated for 3 hours with immune complexes of RA patients' plasma or SF or heat- 
Chemotaxis assay
PMNs were fluorescently labeled for 30 minutes at 37°C with the fluorescent probe calcein- 
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 4 software (GraphPad Software, San Diego, CA). Statistical differences were determined using unpaired Student two-tailed t test (2 groups), or with ANOVA (>2 groups), or with non-parametic wilcoxon matched pairs one-tailed (matched samples). Correlations were determined using non-parametic Spearman correlation coefficient (r). A p value <0.05 was considered statistically significant.
Results
Detection of RF in plasma and synovial fluid of RA patients
The presence of IgM RF, IgG RF and IgA RF was determined in non paired plasma and SF samples of RA patients (see Table I for patient characteristics). Most patients' plasma and SF contained increased IgA RF and IgM RF compared to healthy donors ( Figure 1A ).
In contrast, overlap in IgG RF levels was observed between patient and healthy donor plasma. A strong correlation between presence of IgA RF and IgM RF in patients plasma was observed, but only a weak correlation of IgG RF with either IgA RF or IgM RF was found ( Figure 1B ). 
IgA autoantibodies contribute to NETs release that is dependent on FcaRI
We have previously shown that activation of neutrophils via IgA antibodies is mediated Figure 3A ) and in 4 out of 5 SF samples ( Figure 3C ). In general, the presence of a higher score of IgA RF in plasma ( Figure 3B ) and SF ( Figure 3D ) of patients resulted in more NETs release, which were also responders to MIP8a. By contrast, when a lower amount of
IgA RF was present in the plasma, generally less NETs release was observed, which could also not be blocked by incubation of neutrophils with MIP8a. 
Isolated IgA immune complexes induce release of ROS, lactoferrin and chemotactic factors
To establish the contribution of autoantibody complexes present in plasma or SF in activation of neutrophils, immune complexes were precipitated from RA patients' samples. Additionally, minimal uptake of IgG immune complexes occurred, in contrast to IgA immune complexes, which were taken up avidly by neutrophils ( Figure 4A ). First, heataggregated IgA was used as surrogate IgA immune complexes to show that they are able to induce activation and NETosis (Supplementary Figure 1) . Next, we studied activation of neutrophils by isolated immune complexes from RA patients' plasma or SF.
The production of ROS is an important step in the formation of NETs. As such, we investigated ROS production by neutrophils after addition of isolated immune complexes.
Minimal ROS production was observed over time in resting neutrophils or in cells that were incubated with precipitates of healthy controls ( Figure 4B ). In contrast, when neutrophils were incubated with precipitates of RA patients' plasma or SF, a clear increase in ROS production was observed over time ( Figure 4B ). Furthermore, stimulation of neutrophils with isolated immune complexes of RA patients' plasma or SF resulted in degranulation of cells, which is reflected by lactoferrin release (present in secondary granules) ( Figure   4C ). Supernatants were collected to investigate whether chemotactic stimuli had been released by neutrophils after addition of isolated immune complexes of RA patients' plasma or SF. Neutrophils did not migrate towards supernatants of experiments in which neutrophils were not stimulated or stimulated with plasma of healthy controls. By contrast, supernatants of experiments in which neutrophils were stimulated with isolated immune complexes of RA patients' plasma or SF showed chemotactic activity ( Figure 4D ).
Isolated immune complexes of patients' plasma or SF induce NETs release partly via FcaRI
NETs release was visualized with fluorescent microscopy using real-time video recording after stimulation of neutrophils with isolated immune complexes of RA patients' plasma or SF. Minimal NET formation was demonstrated by unstimulated neutrophils over time ( Figure 5A and Video 1), in contrast to neutrophils that had been exposed to RA patients' plasma or SF (data not shown) or isolated immune complexes of RA patients' plasma or SF ( Figure 5A and Video 2&3). To confirm release of NETs, we performed immunostaining, which demonstrated that extracellular DNA stained positive for both elastase ( Figure   5B ) and MPO ( Figure 5C ). Blocking FcaRI resulted in decreased NET formation after stimulation of neutrophils with isolated immune complexes of RA patients' plasma ( Figure   5D ) or SF ( Figure 5E ), which was not seen when an isotype control antibody was used.
Furthermore, NET release was abrogated in the presence of DNase. Thus, NET release was partly inhibited by blocking FcaRI, supporting that neutrophils are activated via FcaRI by IgA complexes present in plasma and SF of most RA patients. Images of live PMNs stained with a nuclear dye (Hoechst, blue), which were incubated in culture medium containing sytox green (stains extracellular DNA). Cells were followed over time with live-cell microscopy after stimulation with isolated immune complexes from RA patients' plasma (middle panels) or SF (lower panels). Non stimulated PMNs served as control (upper panels). PMNs were stained for (B) elastase and (C) MPO in red and DNA was stained with DAPI (blue), after stimulation of PMNs with PEG 6000 precipitated immune complexes from RA patients' plasma or SF compared to non stimulated cells. Scale bar, 10 mm. (D-E) Quantification of extracellular DNA with sytox green (which reflects NETs) after 3h when PMNs were non stimulated (*, dotted line represents average of NETs release by non-stimulated PMNs) or stimulated with PEG 6000 precipitated (D) RA patients' plasma (•) (E) or SF (■). PMNs were also stimulated with immune complexes of (D) RA patients' plasma (○) or (E) SF (□) in the presence of MIP8a or an isotype control (▽). Extracellular DNA was also measured after stimulation of PMNs with immune complexes of RA patients' plasma or SF in the presence of DNase (x). n.s.: non significant; *p < 0.05; **p > 0.05. Experiments were repeated three times, yielding similar results.
Discussion
Recently it was shown that stimulation of macrophages with ACPA immune complexes in the presence of IgM RF or IgA RF, resulted in increased concentrations of the proinflammatory cytokine TNF-a In recent years, the formation of NETs has increasingly been associated with pathogenesis in different autoimmune diseases, such as SLE
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, RA 35, 36 , psoriasis 42 and vasculitis 43 .
NETs can cause tissue damage. For instance, it was demonstrated that histones, which are major components of NETs, injure the endothelium 44, 45 . Furthermore, the formation of NETs results in exposure of intracellular self molecules which can serve as auto-antigens.
This leads to production of autoantibodies that contribute to autoimmunity, which is most evident in SLE 46 . Immunogenic complexes composed of neutrophil-derived anti-microbial peptides and self-DNA were identified in the sera of SLE patients. Activated neutrophils release these autoantigens, which efficiently trigger innate plasmacytoid dendritic cell (pDC) activation. SLE patients develop autoantibodies to self-DNA and anti-microbial peptides present in NETs, which suggests that these autoantigens are able to trigger B cell activation. It was shown that neutrophils of SLE patients release more NETs than those from healthy controls 46 . Moreover, NETs release is also stimulated by the presence of anti-microbial autoantibodies. Thus neutrophils are able to activate pDCs through the release of NETs and a dysregulation of this pathway may drive chronic pDC activation and auto-immunity in SLE 46 . Additionally, neutrophils in blood and SF of RA patients show enhanced NETs formation compared to healthy controls 35, 36 . Sera from RA patients with high levels of ACPA and/or RF enhanced NETs formation. Accelerated NETs formation has been implicated in RA pathogenesis through externalization of citrullinated autoantigens that may promote aberrant immune responses in the joint and in the periphery 35 .
NETs formation thus likely plays a pathogenic role in RA, although it is unknown whether . It was previously reported that monovalent targeting of FcaRI can induce inhibitory ITAM signaling, which is referred to as ITAMi signaling 48, 49 . As such, it could be possible that the anti-FcaRI mAb MIP8a did not block binding and activation through , which led to increased recruitment of neutrophils. Interestingly, LTB4 concentration is increased in both serum and SF of RA patients [50] [51] [52] , supporting the involvement of neutrophils in joint inflammation.
We now show that IgA RF autoantibodies present in RA patients' plasma and SF potently activate neutrophils, which in response secrete chemoattractants to attract more neutrophils. We previously demonstrated that neutrophil activation and concomitant tissue damage is a direct consequence of FcaRI triggering through IgA autoantibodies in the rare skin blistering disease Linear IgA Bullous Disease (LABD) 19 . Patients with this disease have IgA autoantibodies directed against collagen XVII as well as neutrophil accumulations in the skin, which ultimately leads to extensive skin damage and blister formation 22 . When skin cryosections were incubated with neutrophils and serum of LABD patients (which contained anti-collagen XVII IgA autoantibodies), separation of the dermis and epidermis was observed, which reflects blister formation
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. Importantly, IgAinduced tissue damage was prevented by blocking FcaRI using an anti-FcaRI mAb. It is likely that presence of IgA immune complexes in SF can directly contribute to activation and recruitment of neutrophils into the joints of RA patients through interaction with
FcaRI. The newly recruited neutrophils will then also encounter these complexes and get activated, which will lead to secretion of more chemoattractants, resulting in amplification of neutrophil migration to the joints of RA patients. Moreover, degranulation and release of NETs may result in increased destruction of joint tissue, which may explain why RA patients with high levels of IgA RF immune complexes have worse prognosis. As such,
IgA autoantibodies are not only a predictor for the development of erosive disease of the joints, but may in fact be the cause of tissue destruction.
In conclusion, our results show that neutrophils are activated by IgA RF complexes via FcaRI. Since neutrophils are found in high numbers in the SF of RA patients 53 and IgA complexes are able to recruit and activate neutrophils, this supports their role in inducing joint damage and in this way worsen disease in RA patients. IgA-induced tissue damage by neutrophils might be prevented by blocking FcaRI using anti-FcaRI monoclonal antibody therapy, which may help to alleviate disease in RA patients.
